NAD+ Therapy (Nicotinamide Adenine Dinucleotide)
NAD+ (Nicotinamide Adenine Dinucleotide) is a coenzyme present in every cell of the body. It plays a central role in cellular energy production, mitochondrial function, and DNA repair.
Levels of NAD+ decline with age and metabolic stress.
- Mitochondrial ATP production
- Sirtuin activation (cellular repair pathways)
- Oxidative stress regulation
- Cellular metabolism
- Low energy
- Recovery from metabolic stress
- Age-related decline in cellular function
Appropriateness is determined after physician evaluation.
Compounded NAD+ is not FDA-approved for the diagnosis, treatment, cure, or prevention of disease. Therapy is prescribed based on individualized medical judgment.
- Subcutaneous or intramuscular administration
- Individualized dosing
- Ongoing monitoring as clinically indicated
$300 Total Peptide Program
Includes your medical consultation and one peptide medication, if prescribed.
If therapy is appropriate, medication pricing is discussed transparently before prescribing.
How It Works
You’ll begin with a brief virtual consultation with a licensed medical provider, who will review your medical history and determine whether this therapy may be appropriate for you.
If treatment is recommended, your prescription is sent to a licensed U.S. compounding pharmacy and shipped directly to your home, typically within 3–7 business days.
Consultation Cost
The total cost is $300, which includes:
If a peptide therapy is not clinically appropriate, there is no charge for the visit.
- All therapies are prescribed only when clinically appropriate and based on physician evaluation.
Frequently Asked Questions
Compounded NAD+ is not FDA-approved for the diagnosis, treatment, cure, or prevention of disease. It may be prescribed based on individualized medical evaluation.
NAD+ may be legally prescribed by a licensed physician through a compounding pharmacy when deemed clinically appropriate.
NAD+ is typically administered via subcutaneous or intramuscular injection, depending on physician recommendation.
Individuals with certain medical conditions, or those who are pregnant or breastfeeding, should only consider NAD+ after physician evaluation.